Waiting on FDA: The Long Silence Over Pet Food Transparency Imagine buying birdseed that sometimes contains spoiled grains but no one tells you. That’s a bit like what’s happening with pet food in the U.S. For over three years—1132 days to be exact—pet owners and advocates have been waiting for the FDA’s Center for Veterinary Medicine (CVM) to respond to a petition demanding transparency on pet food ingredients. The law says the FDA should reply within 180 days, but so far, users only got a vague response in early 2023 saying the agency needs more time.
Why does this matter? Because the term “chicken” on a pet food label might mean USDA-approved chicken in one product, but condemned or decomposed chicken in another. Consumers have no way to differentiate since there’s no enforcement requiring detailed disclosure. This leaves many pet owners in the dark about what their furry friends are really eating.
Navigating Regulatory Challenges for Animal Health Startups On another front, emerging animal health companies face their own regulatory hurdles. Karen Greenwood, an expert in FDA processes, shares that even when a new animal drug or product looks safe based on initial studies, real-world use can reveal unexpected issues. Different breeds, diets, and medications can cause side effects not seen early on.
Adverse events must be reported both to manufacturers and the FDA, allowing regulators to react swiftly—sometimes with new warnings or additional studies.
Getting from conditional to full product approval requires extensive, controlled efficacy studies involving hundreds of animals. This rigorous demand ensures that newly introduced animal health products truly benefit pets across a spectrum of real-world conditions.
Disease Threats and Emergency Measures: The Screwworm Case Speaking of real-world threats, the U.S has recently reported its first human case of New World screwworm in 2025, a parasitic insect that causes severe infections. This has prompted a stepped-up response from veterinary and health authorities including the USDA and FDA.
The USDA unveiled a new facility in Texas to help fight back against this invasive pest, using eradication strategies that protect both livestock and pets. The quick federal action underscores the importance of timely and coordinated responses in animal disease management, which also falls under regulatory compliance.
Other FDA Moves in Animal Health Regulatory Space Recent months have seen the FDA actively updating drug labeling rules, seeking public comments on cannabis-derived products in veterinary medicine, and cracking down on unapproved pet drugs. For instance, the FDA issued warnings to multiple companies selling seizure drugs that weren’t approved.
There’s a clear push to strengthen oversight and modernize regulations around animal drugs and food ingredients, aiming to enhance pet safety.
What This Means for Pet Owners and Industry Players
- Pet owners need to be aware that not all pet food ingredients are created or regulated equally.
- Animal health startups cannot take regulatory approval lightly; they must plan for comprehensive studies and post-market surveillance.
- Authorities react swiftly to disease threats like screwworm, showing the crucial role of regulatory frameworks in protecting animal and public health.
- The FDA’s ongoing efforts to update regulations signal a changing landscape—stakeholders must stay informed and compliant.
In this complex regulatory environment, transparency and vigilance are key. Knowing these real-world developments helps pet owners, veterinarians, and companies navigate challenges and advocate for better standards in animal health.
References:
- https://truthaboutpetfood.com/we-have-waited-1132-days-for-fdas-response/
- https://www.news-medical.net/news/20250825/Strategic-tips-for-early-stage-animal-health-companies-facing-regulatory-challenges.aspx
- https://www.nysdental.org/news-publications/lance’s-corner/2025/08/25/fda-issues-health-care-stakeholders-update
- https://www.fda.gov/animal-veterinary/news-events/cvm-updates
- https://www.avma.org/news/issues
